Abstract
PTEN loss stimulates prostate tumor progression by sustaining AKT activation. Nowak et al. (2019. J. Cell Biol. https://doi.org/10.1083/jcb. 201902048) surprisingly show that the AKT-suppressing phosphatase PHLPP2 promotes disease progression in the context of dual PTEN and p53 loss by increasing MYC stability.
Cite
CITATION STYLE
APA
Toivanen, R., & Furic, L. (2019, June 3). A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer. Journal of Cell Biology. Rockefeller University Press. https://doi.org/10.1083/JCB.201904119
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free